GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.87 $1.65 Friday, 19th Apr 2024 ADAP stock ended at $0.98. This is 8.72% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 17.39% from a day low at $0.92 to a day high of $1.08.
90 days $0.691 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
2023-05-25 $1.21 $1.23 $1.11 $1.17 914 546
2023-05-24 $1.23 $1.24 $1.15 $1.20 902 138
2023-05-23 $1.28 $1.31 $1.20 $1.22 627 795
2023-05-22 $1.32 $1.33 $1.27 $1.28 410 420
2023-05-19 $1.32 $1.34 $1.30 $1.31 338 977
2023-05-18 $1.33 $1.38 $1.28 $1.31 450 837
2023-05-17 $1.32 $1.38 $1.28 $1.34 460 292
2023-05-16 $1.36 $1.37 $1.31 $1.31 264 511
2023-05-15 $1.37 $1.43 $1.36 $1.39 542 327
2023-05-12 $1.42 $1.42 $1.35 $1.37 418 063
2023-05-11 $1.41 $1.41 $1.35 $1.36 264 843
2023-05-10 $1.40 $1.44 $1.38 $1.40 257 362
2023-05-09 $1.40 $1.42 $1.36 $1.40 140 634
2023-05-08 $1.42 $1.45 $1.37 $1.40 234 698
2023-05-05 $1.40 $1.42 $1.38 $1.40 459 220
2023-05-04 $1.42 $1.42 $1.36 $1.39 198 326
2023-05-03 $1.36 $1.46 $1.35 $1.40 1 078 086
2023-05-02 $1.40 $1.43 $1.36 $1.37 340 047
2023-05-01 $1.40 $1.46 $1.40 $1.43 610 345
2023-04-28 $1.39 $1.43 $1.33 $1.42 401 305
2023-04-27 $1.36 $1.41 $1.36 $1.36 377 776
2023-04-26 $1.32 $1.39 $1.32 $1.36 345 206
2023-04-25 $1.36 $1.38 $1.29 $1.32 655 054
2023-04-24 $1.35 $1.44 $1.33 $1.38 814 235
2023-04-21 $1.44 $1.46 $1.26 $1.35 1 061 354
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT